HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byung Mun Park Selected Research

Krebs-Henseleit solution

1/2021Cardio-protective effects of angiotensin-(1-5) via mas receptor in rats against ischemic-perfusion injury.
3/2020Similarity and dissimilarity between angiotensin A and angiotensin II in cardiovascular functions in a rat model.
1/2018Alamandine Protects the Heart Against Reperfusion Injury via the MrgD Receptor.
11/2013Cardioprotective effects of angiotensin III against ischemic injury via the AT2 receptor and KATP channels.
8/2012Urotensin II protects ischemic reperfusion injury of hearts through ROS and antioxidant pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byung Mun Park Research Topics

Disease

7Ischemia
01/2021 - 08/2012
5Infarction (Infarctions)
03/2020 - 08/2012
3Reperfusion Injury
01/2018 - 08/2012
1Myocardial Infarction
01/2021
1Hypoxia (Hypoxemia)
11/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Vascular Remodeling
07/2018
1Pulmonary Arterial Hypertension
07/2018
1Inflammation (Inflammations)
01/2016
1Acute Kidney Injury (Acute Renal Failure)
07/2015
1Cardiomegaly (Heart Hypertrophy)
07/2015
1Hypertension (High Blood Pressure)
07/2015
1Renovascular Hypertension (Goldblatt Syndrome)
07/2015
1Body Weight (Weight, Body)
09/2012

Drug/Important Bio-Agent (IBA)

5Krebs-Henseleit solutionIBA
01/2021 - 08/2012
5L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2020 - 08/2012
3Atrial Natriuretic Factor (ANF)IBA
01/2021 - 07/2015
2KATP ChannelsIBA
11/2019 - 11/2013
2urotensin IIIBA
07/2015 - 08/2012
1angiotensin II (1-5)IBA
01/2021
1PD 123319IBA
03/2020
1Losartan (Cozaar)FDA LinkGeneric
03/2020
1antineoplaston A10 (A 10)IBA
03/2020
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
11/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019
1sodium bisulfide (NaHS)IBA
11/2019
1Pinacidil (Pindac)FDA Link
11/2019
12-chloro-5-nitrobenzanilideIBA
11/2019
1Glyburide (Glibenclamide)FDA LinkGeneric
11/2019
1Endothelin Receptors (Endothelin Receptor)IBA
11/2019
1Bosentan (Tracleer)FDA Link
11/2019
1BuffersIBA
11/2019
1Cysteine (L-Cysteine)FDA Link
01/2019
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2019
1angiotensin I (1-9)IBA
07/2018
1AngiotensinsIBA
07/2018
1MonocrotalineIBA
07/2018
1EnzymesIBA
07/2018
1alamandineIBA
01/2018
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2016
1des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
01/2016
1Hormones (Hormone)IBA
07/2015
1ProstaglandinsIBA
07/2015
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2015
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
07/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2015
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2015
1nimesulide (Aulin)IBA
07/2015
1Superoxide DismutaseIBA
11/2013
1Proteins (Proteins, Gene)FDA Link
11/2013
1Adenosine Triphosphate (ATP)IBA
11/2013
1Heme Oxygenase-1IBA
11/2013
1CatalaseIBA
11/2013
1Captopril (Capoten)FDA LinkGeneric
09/2012
1angiotensin I (1-7)IBA
09/2012
1AntioxidantsIBA
08/2012
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2012

Therapy/Procedure

1Ligation
01/2016